Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy and safety of inhaled Technosphere insulin compared to Technosphere placebo in patients with type 2 diabetes mellitus following diabetes education

Trial Profile

Efficacy and safety of inhaled Technosphere insulin compared to Technosphere placebo in patients with type 2 diabetes mellitus following diabetes education

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Apr 2012

At a glance

  • Drugs Insulin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors MannKind Corporation
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 27 Apr 2012 Actual end date Dec 2005 added as reported by ClinicalTrials.gov.
    • 01 Nov 2008 Results published in Diabetes Care.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top